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1. Have you ever forgotten to take medication for your disease? 
2. Have you ever been careless with the hours to take the medicines for your disease? 
3. Did you ever stop to take your medication, because you were feeling better? 
4. Did you ever stop to take medication on your own initiative, after felt worse? 
5. Have you taken a second or more pills for your disease, on your own initiative, after felt worse? 
6. Ever discontinued therapy for their disease for failing to end the drugs? 
7. Did you ever take medication for your disease for some other reason than the indication of the 
doctor? 
Always  
(1 point) 
Usually  
(2 points) 
Often 
 (3 points) 
Sometimes 
 (4 points) 
Rarely  
 (5 points) 
Never 
 (6 points) 
To test the ability of students to be actively involved in the 
implementation of a new service for community pharmacy; 
to explore the acceptability of the system by pharmacies; to 
judge the competency of pharmacists in delivering advanced 
services. 
   Results indicate that while pharmacists and students 
were motivated to use the DAA system, they showed little 
confidence with medication review. Additional sessions 
are needed to implement this service. Patients rated their 
satisfaction with the service provided by students as very 
high (>90%) and indicated they would like to have it 
available at their pharmacy even at a cost (42.9%) or for 
free (42.9%). 
Participants in the study 
Twenty one students participated in patient recruitment 
and most students recruited 2 patients {1-9}. A total of 50 
patients joined the study (nIG=28; nCG=22). From these, 
adherence data could only be collected at 3 months for 
20 patients.  
   
Adherence to medication results 
Results indicate that the use of the DAA system had a 
positive impact on patients’ adherence measured by the 
MAT as the CG obtained the same score at baseline and 
at 3 months (p=0.357), whilst the IG improved 
significantly their score (Median-IGt0=33.5 (SD=4.33); 
Median-IGt3=40.5 (SD=3.89); p=0.017). 
 
  
 
 
 
 
 
 
 
Pill-count at 1 month (IG) was very high (98,7%), leading 
to little effect observed at 3 months (99,5%; p=0.128).  
 
   
 
 
 
 
 
 
Medication Review Results 
From 12 intervention pharmacies, only 4 reviewed 
medication for 10 patients (35,71%), leading to 4 reports 
due to DRP detected and 1 due to PIM detected, 4 of 
which were accepted (80,0%). PIM were detected in 15 
patients by the research team (29,6%). 
      Adherence in the polymedicated elderly is recognised to 
be suboptimal1. The use of dose administration aid (DAA) 
systems has been proposed as an effective tool to reduce 
unintentional non-adherence, especially effective when 
combined with other enhanced services2.  
Study Design: Quasi-experimental. Patients were recruited by 
MPharm students as trainees in community pharmacies 
distributed throughout mainland Portugal.  
Eligibility criteria: inclusion of patients aged ≥ 65, taking ≥ 5 
medicines and living alone or with a partner within the same 
age category.  
Collected data: Sociodemographic, diagnosis and treatment, 
clinical biomarkers and adherence [self-report for both 
groups (MAT3; Fig. 1) and weekly pill-count for intervention 
group (IG)]. Satisfaction survey at the end of study for IG.  
Interventions: Intermediate medication review was proposed 
and pharmacists were instructed to use Beers criteria for 
Portugal4 to detect potentially inappropriate medicines (PIM) 
and/or II Granada Consensus5 to detect DRP. Additionally, 
medicines were delivered using the DAA service.  
Figure 1:  Medication adherence questionnaire 
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Statistical analysis: Univariate and bivariate analysis 
(Wilcoxon; Mann-Whitney; Friedman). 95% CI. 
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